相关实验视频
Updated: May 7, 2026

06:27
Fast and Accurate Exhaled Breath Ammonia Measurement
Published on: June 11, 2014
13.6K
作为未标记的CYP3A4基质的迪索胺:对呼吸测试开发的影响
Valentina Stock1, Rebecca Hofer1, Vera A Spanke2
1Institute for Breath Research, University of Innsbruck, Innrain 80/82, 6020 Innsbruck, Austria.
Bioorganic chemistry
|July 25, 2025
概括
与tolterodine相比,diisopromine显示了增强的生物转化效率和较低的毒性,这使得它成为开发非侵入性CYP试验来预测药物反应的有希望的基质.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药物新陈代谢 药物新陈代谢
- 生物化学 生物化学
背景情况:
- 呼吸试验需要特定的基质产生挥发性代谢物来预测患者的药物反应.
- 托尔特罗丁是一种已知的CYP3A4基质,产生一种挥发性代谢物,但二醇胺的结构差异可能会带来优势.
研究的目的:
- 评估diisopromine作为CYP试验的潜在基质.
- 为了比较diisopromine与tolterodine的生物转化,并评估其适用于药物反应预测的适用性.
主要方法:
- 使用质谱法 (PTR-ToF-MS,LC-MS) 来识别挥发性和非挥发性代谢物.
- 采用了一项实验设计,以优化二醇胺代谢反应条件.
- 通过使用HepG2细胞克隆,研究了不同CYP异型 (CYP3A4,CYP2D6,CYP2C9) 的二醇胺特异性.
主要成果:
- 迪索普罗米因的N-dealkylation是tolterodine的1.5倍,乙的产量是tolterodine的1.4倍.
- 双胺的新陈代谢主要由CYP3A4进行介导,CYP2D6和CYP2C9.9的贡献较小.
- 与托尔特罗丁相比,迪索普罗明的细胞毒性显著降低 (TC50~1000μM).
结论:
- 迪索胺的结构修改提高了生物转化效率,降低了毒性.
- 它有利的代谢特征支持其潜在的开发用于非侵入性CYP试验.
- 这有助于预测患者特异性药物反应.
相关概念视频
Dose-Response Relationship: Selectivity and Specificity
10.2K
Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and...
10.2K
Adrenergic Agonists: Mixed-Action Agents
1.7K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.7K
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
349
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450...
349

